Persistent tissue hypoperfusion improves risk stratification beyond vasopressor dose in refractory septic shock: a secondary analysis of the ANDROMEDA-SHOCK-2 trial. (link.springer.com)

Authors: Kattan E … Hernandez G Journal: Intensive Care Medicine Published: 2026-07-15 DOI: https://doi.org/10.1007/s00134-026-08551-x